Concepts (185)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cortical Spreading Depression | 6 | 2025 | 10 | 2.990 |
Why?
|
| Zinc | 4 | 2013 | 140 | 1.230 |
Why?
|
| NAV1.6 Voltage-Gated Sodium Channel | 1 | 2025 | 24 | 0.960 |
Why?
|
| Brain Stem | 2 | 2016 | 121 | 0.930 |
Why?
|
| Gain of Function Mutation | 1 | 2025 | 115 | 0.910 |
Why?
|
| Seizures | 4 | 2025 | 889 | 0.890 |
Why?
|
| Sodium | 1 | 2025 | 308 | 0.870 |
Why?
|
| Action Potentials | 2 | 2019 | 530 | 0.870 |
Why?
|
| Seizures, Febrile | 1 | 2023 | 29 | 0.810 |
Why?
|
| Nodose Ganglion | 1 | 2022 | 4 | 0.810 |
Why?
|
| Solitary Nucleus | 1 | 2022 | 4 | 0.810 |
Why?
|
| KCNQ2 Potassium Channel | 1 | 2021 | 41 | 0.730 |
Why?
|
| Cation Transport Proteins | 7 | 2016 | 100 | 0.650 |
Why?
|
| Mice, Inbred C57BL | 12 | 2025 | 4822 | 0.650 |
Why?
|
| Autonomic Fibers, Preganglionic | 1 | 2019 | 5 | 0.620 |
Why?
|
| Adrenergic Agonists | 1 | 2019 | 11 | 0.620 |
Why?
|
| Brain | 5 | 2023 | 3225 | 0.620 |
Why?
|
| Medulla Oblongata | 1 | 2019 | 23 | 0.620 |
Why?
|
| Periodicity | 1 | 2019 | 55 | 0.610 |
Why?
|
| Mice | 16 | 2025 | 18911 | 0.530 |
Why?
|
| Excitatory Postsynaptic Potentials | 3 | 2016 | 130 | 0.530 |
Why?
|
| Neurons | 7 | 2016 | 2036 | 0.520 |
Why?
|
| Sp1 Transcription Factor | 3 | 2016 | 45 | 0.490 |
Why?
|
| Electroencephalography | 4 | 2025 | 907 | 0.490 |
Why?
|
| Epilepsy | 1 | 2023 | 892 | 0.480 |
Why?
|
| Nerve Tissue Proteins | 1 | 2021 | 1161 | 0.480 |
Why?
|
| Death, Sudden | 1 | 2015 | 50 | 0.460 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 2 | 2013 | 152 | 0.460 |
Why?
|
| Animals | 21 | 2025 | 36378 | 0.450 |
Why?
|
| Receptors, GABA-A | 1 | 2014 | 59 | 0.450 |
Why?
|
| Membrane Potentials | 2 | 2014 | 317 | 0.440 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 1 | 2016 | 241 | 0.440 |
Why?
|
| Heart | 1 | 2019 | 749 | 0.430 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2016 | 266 | 0.430 |
Why?
|
| Dendrites | 1 | 2012 | 204 | 0.350 |
Why?
|
| Heart Arrest | 1 | 2015 | 376 | 0.340 |
Why?
|
| Stress, Physiological | 1 | 2012 | 271 | 0.340 |
Why?
|
| Mice, Transgenic | 3 | 2025 | 2526 | 0.300 |
Why?
|
| Cadmium | 1 | 2008 | 31 | 0.300 |
Why?
|
| CA1 Region, Hippocampal | 3 | 2014 | 80 | 0.280 |
Why?
|
| Glutathione | 1 | 2008 | 201 | 0.260 |
Why?
|
| Cholestanetriol 26-Monooxygenase | 1 | 2006 | 15 | 0.260 |
Why?
|
| Potassium | 3 | 2023 | 290 | 0.250 |
Why?
|
| Synaptic Transmission | 2 | 2020 | 369 | 0.250 |
Why?
|
| Mutation | 3 | 2016 | 6290 | 0.250 |
Why?
|
| Down-Regulation | 1 | 2008 | 717 | 0.250 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2006 | 142 | 0.240 |
Why?
|
| Copper | 3 | 2016 | 75 | 0.220 |
Why?
|
| Oxidation-Reduction | 3 | 2016 | 465 | 0.220 |
Why?
|
| NAV1.1 Voltage-Gated Sodium Channel | 1 | 2023 | 15 | 0.210 |
Why?
|
| Mice, Knockout | 5 | 2020 | 3981 | 0.210 |
Why?
|
| Patch-Clamp Techniques | 2 | 2014 | 300 | 0.200 |
Why?
|
| Ganglia, Autonomic | 1 | 2022 | 4 | 0.200 |
Why?
|
| Urethane | 1 | 2022 | 6 | 0.200 |
Why?
|
| Membrane Transport Proteins | 3 | 2013 | 186 | 0.200 |
Why?
|
| Vagus Nerve | 1 | 2022 | 47 | 0.200 |
Why?
|
| Carrier Proteins | 3 | 2013 | 1066 | 0.190 |
Why?
|
| Membrane Proteins | 4 | 2023 | 1603 | 0.190 |
Why?
|
| Cerebral Cortex | 1 | 2025 | 481 | 0.190 |
Why?
|
| Bridged Bicyclo Compounds | 1 | 2021 | 4 | 0.190 |
Why?
|
| In Vitro Techniques | 2 | 2013 | 991 | 0.190 |
Why?
|
| Phenylenediamines | 1 | 2021 | 30 | 0.180 |
Why?
|
| Brain Neoplasms | 2 | 2023 | 1407 | 0.180 |
Why?
|
| Anilides | 1 | 2021 | 59 | 0.180 |
Why?
|
| Integrases | 1 | 2022 | 163 | 0.180 |
Why?
|
| Carbamates | 1 | 2021 | 68 | 0.180 |
Why?
|
| Disease Models, Animal | 3 | 2025 | 4779 | 0.180 |
Why?
|
| Organ Culture Techniques | 1 | 2021 | 161 | 0.180 |
Why?
|
| Argininosuccinate Synthase | 2 | 2012 | 25 | 0.180 |
Why?
|
| Hydrolases | 2 | 2012 | 61 | 0.170 |
Why?
|
| Calcium | 3 | 2016 | 1145 | 0.170 |
Why?
|
| Proto-Oncogene Proteins c-myc | 2 | 2012 | 217 | 0.160 |
Why?
|
| Neoplasms, Experimental | 1 | 2020 | 226 | 0.160 |
Why?
|
| Synaptic Potentials | 1 | 2019 | 14 | 0.160 |
Why?
|
| Calcium Channels, T-Type | 1 | 2019 | 13 | 0.160 |
Why?
|
| Synapses | 2 | 2013 | 468 | 0.150 |
Why?
|
| Norepinephrine | 1 | 2019 | 175 | 0.150 |
Why?
|
| Homeostasis | 2 | 2016 | 745 | 0.150 |
Why?
|
| Male | 9 | 2025 | 65694 | 0.150 |
Why?
|
| Sodium Channels | 1 | 2019 | 109 | 0.150 |
Why?
|
| Chelating Agents | 3 | 2015 | 46 | 0.140 |
Why?
|
| Epinephrine | 1 | 2019 | 181 | 0.140 |
Why?
|
| Glioma | 1 | 2023 | 538 | 0.140 |
Why?
|
| Female | 9 | 2025 | 71465 | 0.140 |
Why?
|
| CRISPR-Cas Systems | 1 | 2020 | 292 | 0.140 |
Why?
|
| Base Sequence | 4 | 2009 | 3170 | 0.130 |
Why?
|
| Glioblastoma | 1 | 2020 | 374 | 0.120 |
Why?
|
| Calcium Channels, N-Type | 1 | 2016 | 25 | 0.120 |
Why?
|
| Epilepsy, Absence | 1 | 2016 | 31 | 0.120 |
Why?
|
| Thalamus | 1 | 2016 | 89 | 0.120 |
Why?
|
| Kv1.1 Potassium Channel | 1 | 2015 | 42 | 0.120 |
Why?
|
| Edetic Acid | 2 | 2011 | 25 | 0.120 |
Why?
|
| GABA Antagonists | 1 | 2014 | 20 | 0.120 |
Why?
|
| Potassium Chloride | 2 | 2011 | 55 | 0.120 |
Why?
|
| GABA Agonists | 1 | 2014 | 16 | 0.120 |
Why?
|
| Ciliary Neurotrophic Factor | 1 | 2014 | 10 | 0.110 |
Why?
|
| Propofol | 1 | 2014 | 48 | 0.110 |
Why?
|
| Cisplatin | 1 | 2016 | 287 | 0.110 |
Why?
|
| Pyridazines | 1 | 2014 | 54 | 0.110 |
Why?
|
| Dithionitrobenzoic Acid | 1 | 2013 | 2 | 0.110 |
Why?
|
| Ouabain | 1 | 2013 | 29 | 0.110 |
Why?
|
| Visual Cortex | 1 | 2016 | 131 | 0.110 |
Why?
|
| Cations, Divalent | 1 | 2013 | 21 | 0.100 |
Why?
|
| Microdialysis | 1 | 2013 | 57 | 0.100 |
Why?
|
| Polyethylene Glycols | 2 | 2012 | 252 | 0.100 |
Why?
|
| Intracellular Space | 1 | 2013 | 51 | 0.100 |
Why?
|
| Drug Resistance, Neoplasm | 3 | 2015 | 819 | 0.100 |
Why?
|
| Sodium Azide | 1 | 2012 | 4 | 0.100 |
Why?
|
| tau Proteins | 1 | 2015 | 241 | 0.100 |
Why?
|
| Ethylenediamines | 1 | 2011 | 5 | 0.100 |
Why?
|
| NAD | 1 | 2012 | 47 | 0.090 |
Why?
|
| Parietal Lobe | 1 | 2011 | 49 | 0.090 |
Why?
|
| Glutamic Acid | 1 | 2012 | 207 | 0.090 |
Why?
|
| Astrocytes | 1 | 2014 | 272 | 0.090 |
Why?
|
| Calcium Signaling | 1 | 2012 | 255 | 0.090 |
Why?
|
| Promoter Regions, Genetic | 3 | 2009 | 1417 | 0.080 |
Why?
|
| DNA | 1 | 2016 | 1674 | 0.080 |
Why?
|
| Sp4 Transcription Factor | 1 | 2009 | 4 | 0.080 |
Why?
|
| Hippocampus | 2 | 2014 | 860 | 0.080 |
Why?
|
| Neuroglia | 1 | 2011 | 217 | 0.080 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2009 | 104 | 0.080 |
Why?
|
| Glutamate-Cysteine Ligase | 1 | 2008 | 5 | 0.070 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2015 | 1349 | 0.070 |
Why?
|
| Aging | 1 | 2015 | 1298 | 0.070 |
Why?
|
| Protein Binding | 2 | 2009 | 1833 | 0.070 |
Why?
|
| Melanoma | 2 | 2012 | 964 | 0.070 |
Why?
|
| DNA, Neoplasm | 1 | 2008 | 318 | 0.070 |
Why?
|
| Cell Line, Tumor | 3 | 2012 | 3751 | 0.070 |
Why?
|
| Up-Regulation | 3 | 2015 | 905 | 0.070 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2009 | 2120 | 0.060 |
Why?
|
| Molecular Sequence Data | 2 | 2008 | 3967 | 0.060 |
Why?
|
| Transfection | 1 | 2008 | 1089 | 0.060 |
Why?
|
| DNA Primers | 1 | 2006 | 669 | 0.060 |
Why?
|
| RNA, Messenger | 2 | 2008 | 2899 | 0.060 |
Why?
|
| Rats | 2 | 2012 | 3883 | 0.050 |
Why?
|
| Recombinant Proteins | 1 | 2006 | 1437 | 0.050 |
Why?
|
| Immunoglobulins | 1 | 2023 | 174 | 0.050 |
Why?
|
| Neoplasms | 1 | 2015 | 3025 | 0.040 |
Why?
|
| Humans | 8 | 2023 | 133417 | 0.030 |
Why?
|
| Gene Deletion | 1 | 2020 | 809 | 0.030 |
Why?
|
| Biological Transport, Active | 1 | 2016 | 89 | 0.030 |
Why?
|
| Receptors, Neurotensin | 1 | 2016 | 5 | 0.030 |
Why?
|
| Motor Disorders | 1 | 2016 | 8 | 0.030 |
Why?
|
| Ethosuximide | 1 | 2016 | 14 | 0.030 |
Why?
|
| Platinum Compounds | 1 | 2015 | 6 | 0.030 |
Why?
|
| Luminescent Proteins | 1 | 2016 | 166 | 0.030 |
Why?
|
| Reaction Time | 1 | 2016 | 184 | 0.030 |
Why?
|
| Biological Transport | 1 | 2015 | 369 | 0.030 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2014 | 116 | 0.030 |
Why?
|
| Cell Polarity | 1 | 2014 | 126 | 0.030 |
Why?
|
| Anticonvulsants | 1 | 2016 | 393 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinase | 1 | 2012 | 25 | 0.020 |
Why?
|
| Synaptosomes | 1 | 2012 | 31 | 0.020 |
Why?
|
| Genes, ras | 1 | 2012 | 102 | 0.020 |
Why?
|
| Protein Stability | 1 | 2012 | 172 | 0.020 |
Why?
|
| Purines | 1 | 2012 | 119 | 0.020 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2012 | 149 | 0.020 |
Why?
|
| Ubiquitin | 1 | 2012 | 148 | 0.020 |
Why?
|
| Neurotransmitter Agents | 1 | 2012 | 149 | 0.020 |
Why?
|
| Proteolysis | 1 | 2012 | 193 | 0.020 |
Why?
|
| Polycyclic Compounds | 1 | 2010 | 4 | 0.020 |
Why?
|
| Indicators and Reagents | 1 | 2010 | 52 | 0.020 |
Why?
|
| Hypoxia, Brain | 1 | 2010 | 35 | 0.020 |
Why?
|
| Rats, Wistar | 1 | 2012 | 398 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2012 | 777 | 0.020 |
Why?
|
| MAP Kinase Signaling System | 1 | 2012 | 324 | 0.020 |
Why?
|
| Pyramidal Cells | 1 | 2010 | 172 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2009 | 317 | 0.020 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2009 | 248 | 0.020 |
Why?
|
| Fluorescent Dyes | 1 | 2010 | 270 | 0.020 |
Why?
|
| Brain Injuries | 1 | 2014 | 722 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2009 | 259 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2012 | 1310 | 0.020 |
Why?
|
| Brain Ischemia | 1 | 2010 | 278 | 0.020 |
Why?
|
| Zinc Fingers | 1 | 2008 | 124 | 0.020 |
Why?
|
| RNA Interference | 1 | 2009 | 544 | 0.020 |
Why?
|
| Arginine | 1 | 2009 | 349 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2009 | 1326 | 0.020 |
Why?
|
| Binding Sites | 1 | 2009 | 1370 | 0.020 |
Why?
|
| Glucose | 1 | 2010 | 922 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2012 | 3168 | 0.020 |
Why?
|
| Cell Line | 1 | 2008 | 2836 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2008 | 1755 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2012 | 4897 | 0.010 |
Why?
|
| Pregnancy | 1 | 2012 | 7526 | 0.010 |
Why?
|